Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Exchange Rate Effect: 2018-2024

Historic Exchange Rate Effect for Apellis Pharmaceuticals (APLS) over the last 7 years, with Dec 2024 value amounting to -$659,000.

  • Apellis Pharmaceuticals' Exchange Rate Effect fell 87.28% to $22,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $101,000, marking a year-over-year decrease of 88.65%. This contributed to the annual value of -$659,000 for FY2024, which is 588.15% down from last year.
  • Per Apellis Pharmaceuticals' latest filing, its Exchange Rate Effect stood at -$659,000 for FY2024, which was down 588.15% from $135,000 recorded in FY2023.
  • Apellis Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $359,000 during FY2020, with a 5-year trough of -$2.0 million in FY2021.
  • Its 3-year average for Exchange Rate Effect is -$337,333, with a median of -$488,000 in 2022.
  • Per our database at Business Quant, Apellis Pharmaceuticals' Exchange Rate Effect spiked by 8,875.00% in 2020 and then plummeted by 661.56% in 2021.
  • Over the past 5 years, Apellis Pharmaceuticals' Exchange Rate Effect (Yearly) stood at $359,000 in 2020, then tumbled by 661.56% to -$2.0 million in 2021, then spiked by 75.79% to -$488,000 in 2022, then soared by 127.66% to $135,000 in 2023, then plummeted by 588.15% to -$659,000 in 2024.